Use of human intravenous immunoglobulin for the treatment of 12 dogs with newly diagnosed malignant disease and presumed secondary immune‐mediated thrombocytopenia

Documenti analoghi

• Retrospective evaluation of leflunomide as an adjunctive therapy in dogs with non‐associative immune‐mediated thrombocytopenia: 20 cases (2008‐2021)
  di: D. J. Spear, et al.
  Pubblicazione: (2024)
• Prevalence of anterior uveitis in dogs diagnosed with pyometra
  di: M. Fortuny‐Clanchet, et al.
  Pubblicazione: (2025)
• Magnetic resonance manifestation of diffuse osteopenia in a cat with presumed nutritional secondary hyperparathyroidism, hypocobalaminaemia and thiamine deficiency
  di: A. Skarbek, et al.
  Pubblicazione: (2025)
• Hypocobalaminaemia in dogs with acute gastrointestinal diseases
  di: C. Mattavelli, et al.
  Pubblicazione: (2024)
• Clinical characteristics, treatment, and outcomes of hypoadrenocorticism in dogs
  di: T. N. Sherrod, et al.
  Pubblicazione: (2025)